Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 494 | 801 | 569 | 297 | 179 |
| Gross Profit | 494 | 801 | 569 | 297 | 179 |
| Operating Expenses | 9,175 | 9,664 | 9,348 | 9,933 | 10,569 |
| Operating Income | -8,681 | -8,863 | -8,779 | -9,636 | -10,390 |
| Other Income | 217 | 304 | 391 | 472 | 528 |
| Pre-tax Income | -8,464 | -8,559 | -8,388 | -9,164 | -9,862 |
| Net Income Continuous | -8,464 | -8,559 | -8,388 | -9,164 | -9,862 |
| Net Income | $-8,464 | $-8,559 | $-8,388 | $-9,164 | $-9,862 |
| EPS Basic Total Ops | -2.86 | -2.89 | -2.83 | -3.10 | -3.35 |
| EPS Basic Continuous Ops | -2.86 | -2.89 | -2.83 | -3.10 | -3.35 |
| EPS Diluted Total Ops | -2.86 | -2.89 | -2.83 | -3.10 | -3.35 |
| EPS Diluted Continuous Ops | -2.86 | -2.89 | -2.83 | -3.10 | -3.35 |
| EPS Diluted Before Non-Recurring Items | -2.86 | -2.89 | -2.83 | -3.11 | -3.40 |
| EBITDA(a) | $-8,779 | $-9,082 | $-9,087 | $-10,003 | $-10,748 |